Tag Archives: BLMN

Top Safest Stocks For 2019

The U.S. Dollar has appreciated more than 7% against a basket of currencies since the end of March. While that might not seem like a lot, it’s huge for a developed currency and can cause a lot of problems in a lot of different ways.

—Recommended Link— Watch Your Safest Stocks SOAR 83% In 28 days!
What if you could know at a glance which blue chips will move most in the next 90 days? Would you be ready to cash in? Read more here.

Mostly positive second-quarter earnings were overshadowed by warnings of a stronger dollar and weaker profits for U.S. companies with international exposure.

From Netflix to Illinois Tool Works, management was downbeat as weaker foreign currencies meant lower sales in those markets when converted back to dollars.

One fortunate side effect of all this is that shares of foreign companies have become cheaper in dollar terms. When a company’s shares are primarily priced in another currency and that base weakens then it’s going to act as an artificial weight on the price of the American Depository Receipts (ADRs).

Top Safest Stocks For 2019: Telefonica Brasil S.A.(VIV)

Advisors’ Opinion:

  • [By Paul Ausick]

    Telefônica Brasil SA (NYSE: VIV) dropped about 2.3% Wednesday to set a new 52-week low of $9.72. Shares closed at $9.95 on Tuesday and the stock’s 52-week high is $17.33. Volume totaled around 1.4 million, about 25% below the daily average. The company had no specific news.

  • [By Joseph Griffin]

    Telefonica Brasil SA (NYSE:VIV) has been assigned an average rating of “Hold” from the twelve research firms that are currently covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $14.88.

  • [By Ethan Ryder]

    Windstream (NASDAQ: WIN) and Telefonica Brasil (NYSE:VIV) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

  • [By Max Byerly]

    Vivendi (EPA:VIV) received a €23.50 ($27.33) price target from stock analysts at Barclays in a research note issued on Friday. The brokerage currently has a “neutral” rating on the stock.

  • [By Ethan Ryder]

    UBS Group set a €25.50 ($29.65) target price on Vivendi (EPA:VIV) in a research note issued to investors on Friday morning, www.boersen-zeitung.de reports. The brokerage currently has a buy rating on the stock.

  • [By Ethan Ryder]

    Inventergy Global (OTCMKTS: INVT) and Telefonica Brasil (NYSE:VIV) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends.

Top Safest Stocks For 2019: Wheeler Real Estate Investment Trust, Inc.(WHLR)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    Here are last week’s top-performing penny stocks:

    Penny Stock Sector Current Share Price Last Week’s Gain
    OncoCyte Corp. (NYSE: OCX) Healthcare $4.98 159.38%
    Fortress Biotech (NASDAQ: FBIO) Healthcare $2.47 133.02%
    Trevena Inc. (NASDAQ: TRVN) Healthcare $1.01 86.69%
    Celldex Therapeutics Inc. (NASDAQ: CLDX) Healthcare $0.58 66.82%
    Wheeler Real Estate Investment Trust Inc.(NASDAQ: WHLR) Financial $1.80 63.64%
    Scynexis Inc. (NASDAQ: SCYX) Healthcare $1.13 53.64%
    Eldorado Gold Corp. (NYSE: EGO) Basic Materials $3.98 47.96%
    Novus Therapeutics Inc. (NASDAQ: NVUS) Healthcare $4.15 43.60%
    PHI Inc. (NASDAQ: PHII) Services $4.50 42.14%
    BioTime Inc. (NYSE: BTX) Healthcare $1.33 41.50%

    See Now: Our founder just released his No. 1 pick for 2019. Don’t miss this. See urgent briefing here…

  • [By Ethan Ryder]

    Wheeler Real Estate Investment Trust (NASDAQ:WHLR) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Friday.

  • [By Money Morning News Team]

    Rounding out the top five is a financial services stock, Wheeler Real Estate Investment Trust Inc. (NASDAQ: WHLR), which advanced more than 63% to end the week at $1.80 per share.

Top Safest Stocks For 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By Max Byerly]

    Wall Street analysts expect Bloomin’ Brands Inc (NASDAQ:BLMN) to post earnings of $0.08 per share for the current quarter, Zacks reports. Five analysts have made estimates for Bloomin’ Brands’ earnings. The highest EPS estimate is $0.12 and the lowest is $0.05. Bloomin’ Brands reported earnings of $0.12 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 33.3%. The firm is expected to report its next earnings results on Friday, November 2nd.

  • [By Joseph Griffin]

    Bloomin’ Brands (NASDAQ: BLMN) and Brinker International (NYSE:EAT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

  • [By John Ballard]

    The restaurant industry has had a rough few years. Bloomin’ Brands (NASDAQ:BLMN), owner of Outback Steakhouse, and Brinker International (NYSE:EAT), owner of Chili’s Grill and Bar, were hit particularly hard by traffic trends. Some of this can be attributed to shifts in consumer behavior, as diners more than ever are demanding faster service and quality food preparation. 

Top Safest Stocks For 2019: Farmer Brothers Company(FARM)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Farmer Brothers Co  (NASDAQ:FARM)Q2 2019 Earnings Conference CallFeb. 11, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Farmer Bros (FARM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Trey Thoelcke]

    If Coca-Cola intends to stay focused on coffee for the time being, perhaps Farmer Bros. Co. (NASDAQ: FARM) could be a potential target. This distributor of coffee and other beverage and food products sports a market cap near $500 million.

Top Safest Stocks For 2019: Golden Star Resources Ltd(GSS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Golden Star Resources Ltd. (TSE:GSC) (NYSE:GSS) has been given an average recommendation of “Buy” by the six ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is C$1.48.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Golden Star Resources (GSS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Golden Star Resources Ltd. (NYSEAMERICAN:GSS) was the target of a significant increase in short interest in September. As of September 28th, there was short interest totalling 10,021,831 shares, an increase of 6.9% from the September 14th total of 9,371,344 shares. Based on an average trading volume of 1,038,207 shares, the short-interest ratio is presently 9.7 days. Approximately 4.7% of the company’s shares are sold short.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Golden Star Resources (GSS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Golden Star Resources (GSS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2019

Investment company Matthews Pacific Tiger Fund buys Wise Talent Information Technology Co, sells Shandong Weigao Group Medical Polymer Co, AmorePacific Corp, PT Astra International Tbk during the 3-months ended 2018-06-30, according to the most recent filings of the investment company, Matthews Pacific Tiger Fund. As of 2018-06-30, Matthews Pacific Tiger Fund owns 66 stocks with a total value of $9.1 billion. These are the details of the buys and sells.

New Purchases: 06100, Added Positions: 035420, 600887, 524715, 02611, 030000, YUMC, 532155, 139480, SCMA, 005830, Reduced Positions: 01066, 090430, 00700, 01044, 500114, 00291, CPN, BIDU, 3182, VNM, Sold Out: ASII,

For the details of Matthews Pacific Tiger Fund’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Matthews+Pacific+Tiger+Fund

These are the top 5 holdings of Matthews Pacific Tiger FundChina Resources Beer (Holdings) Co Ltd (00291) – 70,257,775 shares, 3.74% of the total portfolio. Shares reduced by 6.77%Kotak Mahindra Bank Ltd (500247) – 16,123,409 shares, 3.48% of the total portfolio. Ping An Insurance (Group) Co. of China Ltd (02318) – 31,734,000 shares, 3.19% of the total portfolio. Baidu Inc (BIDU) – 1,174,300 shares, 3.13% of the total portfolio. Shares reduced by 3.09%Tencent Holdings Ltd (00700) – 5,336,500 shares, 2.94% of the total portfolio. Shares reduced by 9.34%New Purchase: Wise Talent Information Technology Co Ltd (06100)

Matthews Pacific Tiger Fund initiated holding in Wise Talent Information Technology Co Ltd. The purchase prices were between $32.5 and $32.5, with an estimated average price of $32.5. The stock is now traded at around $28.20. The impact to a portfolio due to this purchase was 0.4%. The holding were 8,838,800 shares as of 2018-06-30.

Top 10 Medical Stocks To Own For 2019: BankFinancial Corporation(BFIN)

Advisors’ Opinion:

  • [By Shane Hupp]

    BankFinancial (NASDAQ:BFIN) and Territorial Bancorp (NASDAQ:TBNK) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on BankFinancial (BFIN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on BankFinancial (BFIN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Own For 2019: Immersion Corporation(IMMR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ForeScout Technologies (NASDAQ: FSCT) and Immersion (NASDAQ:IMMR) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership.

  • [By Ethan Ryder]

    Immersion Co. (NASDAQ:IMMR) major shareholder Senvest Management, Llc sold 177,818 shares of the business’s stock in a transaction on Thursday, June 7th. The shares were sold at an average price of $15.93, for a total transaction of $2,832,640.74. The sale was disclosed in a legal filing with the SEC, which is available through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

  • [By Shane Hupp]

    Shares of Immersion Co. (NASDAQ:IMMR) reached a new 52-week high and low during trading on Friday following a stronger than expected earnings report. The stock traded as low as $13.05 and last traded at $12.34, with a volume of 86458 shares trading hands. The stock had previously closed at $13.21.

  • [By Max Byerly]

    Immersion Co. (NASDAQ:IMMR) has been assigned an average rating of “Hold” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $13.13.

  • [By Evan Niu, CFA]

    Shares of Immersion (NASDAQ:IMMR) got crushed today, down by 23% as of 11:50 a.m. EDT, after the developer of haptic technologies reported second-quarter earnings. An unexpected decline in revenue caught investors off guard.

Top 10 Medical Stocks To Own For 2019: SeaWorld Entertainment, Inc.(SEAS)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    Shares of SeaWorld Entertainment (NYSE:SEAS) have popped today, up by 10% as of 12:20 p.m. EDT, after the company reported first-quarter earnings results. The company enjoyed strong gains in park attendance.

  • [By Daniel B. Kline]

    In this episode of Industry Focus: Consumer Goods, Vincent Shen and Motley Fool contributor Dan Kline take a first pass at understanding what it takes to run a theme park with three of the biggest names in the industry — Six Flags (NYSE:SIX), Cedar Fair (NYSE:FUN), and SeaWorld (NYSE:SEAS).

  • [By Rick Munarriz]

    Investors were ready for SeaWorld Entertainment (NYSE:SEAS) to post its strongest growth in five years on Tuesday morning, and they got a whole lot more. Shares of the marine-life park operator are hitting 11-month highs after the company announced head-turning financial results. 

Top 10 Medical Stocks To Own For 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Jennison Associates LLC raised its position in shares of Bloomin’ Brands Inc (NASDAQ:BLMN) by 15.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 59,634 shares of the restaurant operator’s stock after purchasing an additional 8,083 shares during the quarter. Jennison Associates LLC owned 0.06% of Bloomin’ Brands worth $1,199,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Bloomin’ Brands (NASDAQ:BLMN) from a hold rating to a sell rating in a research note issued to investors on Tuesday.

  • [By Max Byerly]

    Wall Street analysts expect Bloomin’ Brands Inc (NASDAQ:BLMN) to post earnings of $0.08 per share for the current quarter, Zacks reports. Five analysts have made estimates for Bloomin’ Brands’ earnings. The highest EPS estimate is $0.12 and the lowest is $0.05. Bloomin’ Brands reported earnings of $0.12 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 33.3%. The firm is expected to report its next earnings results on Friday, November 2nd.

  • [By John Ballard]

    The restaurant industry has had a rough few years. Bloomin’ Brands (NASDAQ:BLMN), owner of Outback Steakhouse, and Brinker International (NYSE:EAT), owner of Chili’s Grill and Bar, were hit particularly hard by traffic trends. Some of this can be attributed to shifts in consumer behavior, as diners more than ever are demanding faster service and quality food preparation. 

  • [By Dan Caplinger]

    Thursday was a volatile day on Wall Street, as major stock indexes lost a lot of ground early in the day but then rebounded to finished mixed. Gains for the Nasdaq Composite came even as Dow Jones Industrial Average fell modestly, and although investors spent much of the session trying to parse through the implications of the latest economic report on retail sales, earnings played a key role in moving many well-known stocks. Marathon Oil (NYSE:MRO), AstraZeneca (NYSE:AZN), and Bloomin’ Brands (NASDAQ:BLMN) were among the top performers. Here’s why they did so well.

  • [By Joseph Griffin]

    Bloomin’ Brands (NASDAQ: BLMN) and Brinker International (NYSE:EAT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Top 10 Medical Stocks To Own For 2019: MV Oil Trust(MVO)

Advisors’ Opinion:

  • [By Max Byerly]

    MV Oil Trust (NYSE: MVO) and Petroleo Brasileiro SA Petrobras (NYSE:PBR.A) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

  • [By Stephan Byrd]

    Jones Energy (NYSE: MVO) and MV Oil Trust (NYSE:MVO) are both small-cap oils/energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, risk and valuation.

Top 10 Medical Stocks To Own For 2019: Acacia Research Corporation(ACTG)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Acacia Research (NASDAQ:ACTG) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Acacia Research earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.8999050024634 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Acacia Research alerts:

    Insider Selling: Acacia Research Corp (ACTG) President Sells 46,143 Shares of Stock (americanbankingnews.com) Insider Selling: Acacia Research Corp (ACTG) President Sells 66,115 Shares of Stock (americanbankingnews.com) Insider Buying: Acacia Research Corp (ACTG) Insider Acquires 10,000 Shares of Stock (americanbankingnews.com) It may surprise you: OncoSec Medical Incorporated (NASDAQ:ONCS), Mizuho Financial Group, Inc. (NYSE:MFG … (thestreetpoint.com)

    Shares of NASDAQ ACTG traded down $0.05 during midday trading on Tuesday, hitting $3.45. 1,710 shares of the company traded hands, compared to its average volume of 147,059. Acacia Research has a 12-month low of $3.25 and a 12-month high of $5.50. The stock has a market capitalization of $173.23 million, a P/E ratio of 1.16 and a beta of 0.94.

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top 10 Medical Stocks To Own For 2019: Interactive Brokers Group, Inc.(IBKR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    UBS Group AG grew its position in Interactive Brokers Group, Inc. (NASDAQ:IBKR) by 20.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,665 shares of the financial services provider’s stock after purchasing an additional 4,558 shares during the quarter. UBS Group AG’s holdings in Interactive Brokers Group were worth $1,793,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Gamble Jones Investment Counsel increased its stake in shares of Interactive Brokers Group, Inc. (NASDAQ:IBKR) by 1.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,263 shares of the financial services provider’s stock after purchasing an additional 918 shares during the period. Gamble Jones Investment Counsel’s holdings in Interactive Brokers Group were worth $4,139,000 as of its most recent SEC filing.

  • [By Jon C. Ogg]

    Interactive Brokers Group Inc. (NASDAQ: IBKR) has a market cap of almost $26 billion, and its shares were trading basically flat at $62.00, after having been down about 1% in earlier trading indications. The consensus analyst target is $70.50, and the 52-week range is $39.70 to $80.32.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Interactive Brokers Group (IBKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Compass Point started coverage on shares of Interactive Brokers Group (NASDAQ:IBKR) in a research note published on Tuesday. The brokerage issued a neutral rating and a $74.00 price target on the financial services provider’s stock.

Top 10 Medical Stocks To Own For 2019: Nuveen Preferred Income Opportunites Fund(JPC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Hollencrest Capital Management decreased its stake in Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) by 30.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,587 shares of the financial services provider’s stock after selling 9,649 shares during the period. Hollencrest Capital Management’s holdings in Nuveen Preferred & Income Oprtnts Fnd were worth $200,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) announced a monthly dividend on Wednesday, August 1st, NASDAQ reports. Shareholders of record on Wednesday, August 15th will be given a dividend of 0.061 per share by the financial services provider on Tuesday, September 4th. This represents a $0.73 annualized dividend and a yield of 7.75%. The ex-dividend date is Tuesday, August 14th.

  • [By Ethan Ryder]

    News headlines about Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) have trended positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Nuveen Preferred & Income Oprtnts Fnd earned a media sentiment score of 0.42 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 48.1302177844966 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Top 10 Medical Stocks To Own For 2019: (RUP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Rupee (CURRENCY:RUP) traded down 0.9% against the U.S. dollar during the one day period ending at 14:00 PM ET on October 12th. Rupee has a total market capitalization of $802,724.00 and $4.00 worth of Rupee was traded on exchanges in the last day. During the last seven days, Rupee has traded 0% lower against the U.S. dollar. One Rupee coin can now be purchased for approximately $0.0323 or 0.00000515 BTC on exchanges including CoinExchange and CryptoBridge.

  • [By Max Byerly]

    Rupee (CURRENCY:RUP) traded 10.1% higher against the US dollar during the 24 hour period ending at 16:00 PM ET on September 23rd. Over the last week, Rupee has traded 73.1% higher against the US dollar. One Rupee coin can now be bought for $0.0169 or 0.00000252 BTC on major exchanges including CoinExchange and CryptoBridge. Rupee has a total market capitalization of $415,606.00 and approximately $267.00 worth of Rupee was traded on exchanges in the last day.

  • [By Shane Hupp]

    Rupert Resources Ltd (CVE:RUP) insider Alan Douglas Brimacombe purchased 25,000 shares of Rupert Resources stock in a transaction that occurred on Wednesday, May 30th. The stock was bought at an average cost of C$1.03 per share, for a total transaction of C$25,750.00.

  • [By Stephan Byrd]

    Rupert Resources Ltd (CVE:RUP) insider Alan Douglas Brimacombe sold 30,000 shares of the business’s stock in a transaction dated Thursday, August 9th. The shares were sold at an average price of C$0.95, for a total value of C$28,500.00.

Top 10 Medical Stocks To Own For 2019: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Teachers Advisors LLC increased its position in shares of Immunomedics (NASDAQ:IMMU) by 14.9% in the 4th quarter, HoldingsChannel reports. The firm owned 211,706 shares of the biopharmaceutical company’s stock after purchasing an additional 27,385 shares during the period. Teachers Advisors LLC’s holdings in Immunomedics were worth $3,421,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Celldex Therapeutics (NASDAQ: CLDX) and Immunomedics (NASDAQ:IMMU) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings.

  • [By Logan Wallace]

    Rock Springs Capital Management LP bought a new position in Immunomedics, Inc. (NASDAQ:IMMU) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 450,000 shares of the biopharmaceutical company’s stock, valued at approximately $6,575,000. Rock Springs Capital Management LP owned 0.27% of Immunomedics at the end of the most recent reporting period.

  • [By Logan Wallace]

    Immunomedics, Inc. (NASDAQ:IMMU) Director Venbio Select Advisor Llc bought 575,000 shares of the company’s stock in a transaction on Friday, June 15th. The stock was bought at an average cost of $24.00 per share, for a total transaction of $13,800,000.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Immunomedics (IMMU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After unveiling positive results for its lead drug, sacituzumab govitecan, in breast cancer at the influential American Society of Clinical Oncology (ASCO) conference, shares in Immunomedics (NASDAQ:IMMU) rallied by as much as 14.7% today before settling in for a gain of 9.3% at 3 p.m. EDT.

Top Insurance Stocks To Invest In 2019

News headlines about Arch Capital Group (NASDAQ:ACGL) have been trending positive on Thursday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Arch Capital Group earned a media sentiment score of 0.47 on Accern’s scale. Accern also gave media headlines about the insurance provider an impact score of 46.6471900785068 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Here are some of the news stories that may have effected Accern’s analysis:

Top Insurance Stocks To Invest In 2019: Versum Materials, Inc. (VSM)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about Versum Materials (NYSE:VSM) have been trending somewhat positive recently, Accern reports. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Versum Materials earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the basic materials company an impact score of 46.4354866491979 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Max Byerly]

    Penn Capital Management Co. Inc. reduced its stake in shares of Versum Materials (NYSE:VSM) by 5.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 253,960 shares of the basic materials company’s stock after selling 15,004 shares during the quarter. Penn Capital Management Co. Inc. owned about 0.23% of Versum Materials worth $9,571,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Barrow Hanley Mewhinney & Strauss LLC lowered its stake in Versum Materials (NYSE:VSM) by 0.3% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 6,309,010 shares of the basic materials company’s stock after selling 19,336 shares during the quarter. Barrow Hanley Mewhinney & Strauss LLC owned 0.06% of Versum Materials worth $237,408,000 at the end of the most recent quarter.

Top Insurance Stocks To Invest In 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By Max Byerly]

    ILLEGAL ACTIVITY NOTICE: “Bloomin’ Brands (BLMN) Receives $22.63 Consensus Price Target from Analysts” was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/3379609/bloomin-brands-blmn-receives-22-63-consensus-price-target-from-analysts.html.

  • [By Joseph Griffin]

    Bloomin’ Brands (NASDAQ: BLMN) and Brinker International (NYSE:EAT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

  • [By Logan Wallace]

    These are some of the media stories that may have effected Accern Sentiment’s scoring:

    Get First Majestic Silver alerts:

    Zacks: Analysts Anticipate First Majestic Silver Corp. (AG) Will Announce Earnings of $0.03 Per Share (americanbankingnews.com) News Report of Sizzling Basic materials Stock: First Majestic Silver Corp. (AG) (nasdaqplace.com) Stock in the Wall Street Spotlight: First Majestic Silver Corp. (AG) (nysewired.com) Is the Stock Overvalued? First Majestic Silver Corp. (NYSE:AG) (nasdaqjournal.com) Stocks in the Spotlight: Oasis Petroleum Inc. (NYSE:OAS), Bloomin’ Brands, Inc. (NASDAQ:BLMN), First Majestic Silver … (journalfinance.net)

    Shares of First Majestic Silver opened at $7.30 on Friday, MarketBeat.com reports. First Majestic Silver has a 12-month low of $4.93 and a 12-month high of $8.73. The company has a market capitalization of $1.41 billion, a P/E ratio of -182.50 and a beta of 0.30. The company has a debt-to-equity ratio of 0.21, a current ratio of 4.41 and a quick ratio of 4.15.

Top Insurance Stocks To Invest In 2019: Neovasc Inc.(NVCN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Neovasc Inc. (NASDAQ: NVCN) fell about 21% Wednesday to post a new 52-week low of $0.26 after closing at $0.33 on Tuesday. The 52-week high is $2.12. Volume of about 7.3 million was around 7 times the daily average. The medical device maker had no specific news.

  • [By Max Byerly]

    Neovasc Inc. (NASDAQ:NVCN) (TSE:NVC) was the target of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 74,020,430 shares, a growth of 55.3% from the April 13th total of 47,655,636 shares. Approximately 83.5% of the company’s shares are short sold. Based on an average daily volume of 87,826,510 shares, the short-interest ratio is presently 0.8 days.

  • [By Paul Ausick]

    Neovasc
    On May 15, medical device maker Neovasc Inc. (NASDAQ: NVCN) asked shareholders to approve a 1-for-100 reverse stock split at the company’s June 4 annual general meeting. Short interest in the stock soared more than 34% in the two-week period until May 31. Short sellers piled in and amassed nearly 98 million shares, about half of the company’s float. Shares closed $0.03 on Monday in a 52-week range of $0.03 to $1.89.

Hot Medical Stocks To Invest In Right Now

Natixis Advisors L.P. decreased its position in shares of OGE Energy Corp. (NYSE:OGE) by 35.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,287 shares of the utilities provider’s stock after selling 13,258 shares during the period. Natixis Advisors L.P.’s holdings in OGE Energy were worth $796,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in OGE. Amica Retiree Medical Trust acquired a new position in OGE Energy during the 4th quarter worth $109,000. Assetmark Inc. lifted its position in OGE Energy by 120.2% during the 4th quarter. Assetmark Inc. now owns 3,568 shares of the utilities provider’s stock worth $117,000 after acquiring an additional 1,948 shares during the last quarter. HL Financial Services LLC acquired a new position in shares of OGE Energy during the first quarter valued at about $207,000. Greenwich Wealth Management LLC acquired a new position in shares of OGE Energy during the first quarter valued at about $211,000. Finally, Koch Industries Inc. acquired a new position in shares of OGE Energy during the fourth quarter valued at about $297,000. 63.32% of the stock is owned by hedge funds and other institutional investors.

Hot Medical Stocks To Invest In Right Now: Finjan Holdings, Inc.(FNJN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Finjan (NASDAQ: FNJN) and Dolby Laboratories (NYSE:DLB) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk.

  • [By Logan Wallace]

    The Joint (NASDAQ: JYNT) and Finjan (NASDAQ:FNJN) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Finjan (FNJN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Marathon Patent Group (NASDAQ: MARA) and Finjan (NASDAQ:FNJN) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Hot Medical Stocks To Invest In Right Now: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the media stories that may have effected Accern Sentiment’s scoring:

    Get First Majestic Silver alerts:

    Zacks: Analysts Anticipate First Majestic Silver Corp. (AG) Will Announce Earnings of $0.03 Per Share (americanbankingnews.com) News Report of Sizzling Basic materials Stock: First Majestic Silver Corp. (AG) (nasdaqplace.com) Stock in the Wall Street Spotlight: First Majestic Silver Corp. (AG) (nysewired.com) Is the Stock Overvalued? First Majestic Silver Corp. (NYSE:AG) (nasdaqjournal.com) Stocks in the Spotlight: Oasis Petroleum Inc. (NYSE:OAS), Bloomin’ Brands, Inc. (NASDAQ:BLMN), First Majestic Silver … (journalfinance.net)

    Shares of First Majestic Silver opened at $7.30 on Friday, MarketBeat.com reports. First Majestic Silver has a 12-month low of $4.93 and a 12-month high of $8.73. The company has a market capitalization of $1.41 billion, a P/E ratio of -182.50 and a beta of 0.30. The company has a debt-to-equity ratio of 0.21, a current ratio of 4.41 and a quick ratio of 4.15.

  • [By Max Byerly]

    ILLEGAL ACTIVITY NOTICE: “Bloomin’ Brands (BLMN) Receives $22.63 Consensus Price Target from Analysts” was published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/3379609/bloomin-brands-blmn-receives-22-63-consensus-price-target-from-analysts.html.

  • [By Joseph Griffin]

    Bloomin’ Brands (NASDAQ: BLMN) and Brinker International (NYSE:EAT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Hot Medical Stocks To Invest In Right Now: Corning Incorporated(GLW)

Advisors’ Opinion:

  • [By Matthew Cochrane]

    Let’s take a closer look at Corning Incorporated (NYSE:GLW), Mastercard Inc. (NYSE:MA), and Skyworks Solutions Inc. (NASDAQ:SWKS) so I can explain why I personally own all three and why, if you’re also in your 40s, you might want to consider them for your own portfolio.

  • [By Peter Graham]

    Back on December 5th of 2013, we added Corning (GLW) to our list around $16 and change. The stock ended up moving to a high of just over $25 per share early last year for roughly a 50% gain. Well, the stock has since come off again trading all the way back down to under $16 per share back in August of last year, before finding its way back up above $18 just yesterday. The context here is two-fold. First, the valuation metrics for GLW are once again suggesting another undervalued opportunity for a Company that is the clear leader in specialty glass and ceramics.

  • [By Steve Symington, Maxx Chatsko, and Brian Feroldi]

    To that end, we asked three top Motley Fool contributors to each pick a stock they think you would be wise to purchase and hold for the next 50 years. Read on to see why they like Corning (NYSE:GLW), Accenture (NYSE:ACN), and A.O. Smith (NYSE:AOS).

  • [By Anders Bylund, Timothy Green, and Steve Symington]

    We asked a handful of your fellow investors here at The Motley Fool to come up with a few examples of this. Read on to see why dividend investors should look intoCisco Systems(NASDAQ:CSCO),International Business Machines(NYSE:IBM), and Corning(NYSE:GLW) right now.

  • [By Timothy Green, Leo Sun, and Steve Symington]

    If you’re looking for high-yield stocks to buy, three of our contributors have some ideas. Here’s why you should consider adding Corning (NYSE:GLW), Cisco Systems (NASDAQ:CSCO), and Seagate Technology (NASDAQ:STX) to your dividend portfolio.

  • [By Matthew Cochrane]

    Since announcing its Strategy and Capital Allocation Framework almost three years ago, Corning (NYSE:GLW) has returned a staggering $10 billion to shareholders, through dividends and buybacks. Earlier this year, Corning authorized a 16% increase in its dividend; since the framework, a plan outlining the company’s 2016-19 leadership priorities, was announced, the dividend has increased a whopping 50%! That’s a lot of money!

Hot Medical Stocks To Invest In Right Now: Southern Company (SO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    SevenBridge Financial Group LLC cut its holdings in shares of Southern Co (NYSE:SO) by 4.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,117 shares of the utilities provider’s stock after selling 1,208 shares during the quarter. SevenBridge Financial Group LLC’s holdings in Southern were worth $1,193,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    QCI Asset Management Inc. NY trimmed its stake in Southern (NYSE:SO) by 91.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,421 shares of the utilities provider’s stock after selling 182,905 shares during the quarter. QCI Asset Management Inc. NY’s holdings in Southern were worth $733,000 as of its most recent SEC filing.

  • [By Reuben Gregg Brewer]

    If you’re retired, you’ve likely shifted from building your nest egg to trying to live off of your savings. That means you’ll want to look at stocks that are relatively safe and pay a generous dividend. Investors have punished the stocks of giant U.S. utility Southern Company (NYSE:SO) and packaged-food specialist General Mills (NYSE:GIS) for what are likely to be near-term problems, leading to big dividend yields.

  • [By Maxx Chatsko]

    Many major utilities are now ramping up investments in cost-saving, margin-boosting energy efficiency programs. In fact, there’s a strong correlation between the most ambitious renewable energy investment strategies and energy efficiency programs. Some utilities have a lot of catching up to do.

    Xcel Energy (NASDAQ:XEL) has saved 13,000 GWh of electricity consumption across its network over the years, including 9,000 GWh since 2005. The company has an ambitious plan to retire coal-fired power plants and build new wind and solar power capacity, which, when coupled with energy efficiency, could allow it to generate 45% of its electricity from renewables in 2027. Additionally, fuel-related expenses would drop from 47% of capital investments in 2010 to just 28% in 2027. That would free up more cash flow for dividends or growth projects — or both. PG&E (NYSE:PCG) recently filed a plan to retire an aging fossil fuel power plant with distributed solar and energy efficiency programs, as discussed on a recent quarterly conference call with investors. The utility also offers some of the most ambitious customer rebates in the country, with up to $5,500 per household. Southern Company (NYSE:SO) has saved 2,700 GWh of electricity consumption across its network since 2000. By 2020, it will have invested $1 billion total in energy efficiency programs, although that lags well behind more ambitious peers. Dominion Energy (NYSE:D) was ranked second to last among all utilities in the country in energy efficiency by the American Council for an Energy Efficient Economy. That leaves plenty of room for improvement. A recent report suggests it’s possible to reduce new home energy consumption in Virginia (the company’s home state) by 60%, saving the utility billions in capital investments in the next decade by avoiding the need to build new facilities. Those efforts could also save customers $1.7 billion, but the utility’s most recent plan does not prioritize energy efficien

  • [By Shane Hupp]

    SSE (OTCMKTS: SSEZY) and Southern (NYSE:SO) are both large-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

  • [By ]

    And while it’s imperative that you don’t risk money you’re going to count on in the next several years in investments that can quickly lose a lot of value and be very slow to — if ever — recover, high-quality dividend stocks can still serve an important part in providing the best mix of income for today and long-term capital appreciation for down the road. To help you find the best dividend stocks for your retirement, three Motley Fool investors did some research and came back with Hasbro, Inc. (NASDAQ:HAS), Southern Co. (NYSE:SO), and Kinder Morgan Inc. (NYSE:KMI).

Top 10 Blue Chip Stocks To Invest In 2019

Shutterstock

Dont take any dividends for granted today. Business disruption is accelerating as entire industries are being eaten alive.

Uber and Lyft? Killed cabs.

Amazon (AMZN)? Its crushing retail, and starving their REIT landlords right before our very eyes.

And soon, they might team up to offer more same day deliveries and make more rivals obsolete!

These types of disturbances have added a new layer to contrarian investing. Before, it was as simple as buying stocks when they were out-of-favor and holding them until they became back in vogue. The Dogs of the Dow strategy, for example, usually beat the market by banking the highest blue chip dividend yields a sign that the tide was ready to turn back in the dogs favor.

Top 10 Blue Chip Stocks To Invest In 2019: Exactech Inc.(EXAC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

Top 10 Blue Chip Stocks To Invest In 2019: NEW GOLD INC.(NGD)

Advisors’ Opinion:

  • [By Paul Ausick]

    New Gold Inc. (NYSEAMERICAN: NGD) dropped about 2.9% Monday to post a new 52-week low of $2.35. Shares closed at $2.42 on Friday and the stock’s 52-week high is $4.25. Volume was about 10% below the daily average of around 5.8 million shares. The gold mining company had no news.

  • [By Dan Caplinger]

    The stock market lost ground on Monday, sending major market benchmarks lower by more than half a percentage point. The Dow lost its grip on the 20,000 mark in the wake of concerns about economic growth and new U.S. immigration policy, and some believe that the broader geopolitical climate could have a negative impact on global commerce that in turn could start affecting multinational corporations’ business prospects. In addition, bad news from some individual companies weighed on the markets, and Transocean (NYSE:RIG), Rite Aid (NYSE:RAD), and New Gold (NYSEMKT:NGD) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Paul Ausick]

    New Gold Inc. (NYSEAMERICAN: NGD) dropped about 3.8% Thursday to post a new 52-week low of $2.28. Shares closed at $2.37 on Wednesday and the stock’s 52-week high is $4.25. Volume was about 15% below the daily average of around 5.9 million shares. The company had no specific news.

Top 10 Blue Chip Stocks To Invest In 2019: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By David Zeiler]

    Bill Patalon’s initial stock pick was Galapagos NV (Nasdaq ADR: GLPG), a Belgian biotech company.

    Patalon was attracted to Galapagos’ strategy to target “orphan diseases,” afflictions that strike rarely and so often go ignored by the Big Pharma companies. He also liked that Galapagos had more than 50 drug discovery programs underway, and that it already had licensing agreements with several bigger players in the industry.

  • [By Stephen Mack]

    Our investing experts have made some tremendous picks over the last several years, outperforming the S&P 500 by 100%, 200%, or even as much as 700% in the case of Money Morning Executive Editor Bill Patalon’s 2012 pick of Galapagos NV (Nasdaq: GLPG).

  • [By Stephen Mack]

    Galapagos NV (Nasdaq: GLPG) is our big winner so far, gaining 578.8% since Money Morning Executive Editor Bill Patalon shared his recommendation with Money Morning readers in April 2012. The S&P 500 has gained 75.4% in the same time. Bill has renewed his recommendation for the Belgian biotech several times over the years, saying in 2016 that it has “an established history of piling on gains.” With an average gain of 110% a year, it’s hard to argue with that.

Top 10 Blue Chip Stocks To Invest In 2019: lululemon athletica inc.(LULU)

Advisors’ Opinion:

  • [By Chris Lange]

    Lululemon Athletica Inc. (NASDAQ: LULU) will report its most recent quarterly results on Wednesday as well. The consensus estimates are EPS of $0.52 and $609.71 million in revenue. Shares traded at $67.22 on Friday, in a 52-week range of $47.26 to $72.70. The consensus price target is $65.50.

  • [By Chris Lange]

    Lululemon Athletica Inc. (NASDAQ: LULU) is set to release its most recent quarterly results on Tuesday. The consensus forecast calls for $1.27 in EPS and $911.42 million in revenue. Shares traded on Fridays close at $79.51. The consensus price target is $84.33, and the 52-week range is $47.26 to $83.98.

  • [By Lisa Levin]

    Shares of Lululemon Athletica inc. (NASDAQ: LULU) got a boost, shooting up 15 percent to $68.99 after the company reported stronger-than-expected earnings for its third quarter and announced a $100 million stock buyback plan.

  • [By Peter Graham]

    Athletic apparel stock Lululemon Athletica inc (NASDAQ: LULU) reported Q2 2017 earnings after the Thursday market close with results toppingexpectations as online sales surged 30% after an effort to beef up the eCommerce strategy plus the Company raised its outlook. Net revenuegrew 13% to$581.1 millionas total comparable sales increased 7% and comparable store sales increased 2%, or increased by 2% on a constant dollar basis. Direct to consumer net revenue increased 29%, or increased 30% on a constant dollar basis. During the quarter the Company held an online warehouse sale. Excluding the impact of this sale, direct to consumer net revenue increased 15%, or increased 16% on a constant dollar basis. Net income was $48.711 million versus net income of $53.625 million. The Company ended the second quarter of fiscal 2017 with $721.2 million in cash and cash equivalents compared to $535.3 million at the end of the second quarter of fiscal 2016. The CEO commented:

  • [By Paul Ausick]

    Lululemon Athletica Inc. (NASDAQ: LULU) reported fiscal second-quarter 2017 results after markets closed Thursday afternoon. The yoga gear maker reported adjusted diluted earnings per share (EPS) of $0.39 on revenues of $581.1 million, compared with EPS of $0.38 on revenues of $514.5 million in the same period a year ago. The consensus estimates called for EPS of $0.35 on revenues of $567.6 million.

  • [By Peter Graham]

    Athletic apparel stock Lululemon Athletica inc (NASDAQ: LULU)reported earnings for the first quarter ended April30, 2017along witha plan to restructure its ivivva operations. Net revenuerose 5% to$520.3 millionas total comparable sales decreased 1% whiledirect to consumer net revenue was flat. Net income was $31.246 million versus $45.336 million. In addition, the earnings report stated:

Top 10 Blue Chip Stocks To Invest In 2019: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Aimmune Therapeutics Inc (NASDAQ: AIMT) got a boost, shooting up 35 percent to $34.73 in response to failed DBVT peanut allergy trial.

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

  • [By Jim Robertson]

    Small cap clinical-stage biopharmaceutical stock Aimmune Therapeutics (NASDAQ: AIMT) is aclinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune Therapeutics first investigational biologic product using CODIT⒙is AR101 for the treatment of peanut allergy.AR101 has received the FDAs Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials where enrollment was announced last month.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Chris Lange]

    Aimmune Therapeutics Inc. (NASDAQ: AIMT) is looking for Phase 3 data for in its Palisade trial of AR101 in February. Specifically, this trial is looking to treat peanut allergies. Shares closed trading most recently at $37.20, with a consensus price target of $57.11 and a 52-week range of $15.97 to $40.65.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11

Top 10 Blue Chip Stocks To Invest In 2019: Mallinckrodt plc(MNK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after its earnings topped the Street consensus but offered commentary that spooked investors.

    Agence France-Presse/Getty Images

    Shares of Mallinckrodt dropped 9.1% to $52.42, while the S&P 500 rose 0.1%.

    Barclays analyst Douglas Tsao and Morgan Williams callMallinckrodt’s plunge “outsized.” They explain why:

    In our view the sell-off afterMallinckrodt reported CY3Q16 earnings is outsized considering much of the disclosure on the call was largely expected, including specialty generics weakness and the 2017 outlook, which seemed relatively mild. While outsized Acthar contribution to EBITDA may be accounting for some of the sell-off, wed argue that there is benefit to the brand outperforming, especially considering the need to offset Therakos production issues in CY4Q16 and CY1Q17 as well as specialty generics weakness. We recognize some lingering headline risk associated with media reports criticizing the cost of Acthar to Medicare, after CMS released its prescription drug spending dashboard.

    Mallinckrodt’s market capitalization fell to $5.7 billion today from $6.2 billion yesterday. It reported net income of $306 million on revenue of $3.3 billion in 2015.

    This marks the third time in less than two weeks that Mallinckrodt was the S&P 500′s biggest loser.

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today as weakness that began last month even before its fourth-quarter earnings continued into year end.

    Agence France-Presse/Getty Images

    Mallinckrodtdropped 2.7% to $51.77 today, while the S&P 500 rose 0.2% to 2,268.88.

    Mallinckrodt was the biggest loser in the S&P 500 for two consecutive days in mid-November, and again after reporting its earnings.

    Mallinckrodt’s market capitalization fell to $5.5 billion today from $5.6 billion yesterday. It reported net income of $489 million on sales of $3.38 billion in fiscal 2016.

    Mallinckrodt has dropped 31% so far this year.

  • [By Johanna Bennett]

    Sell-side analysts continue to defend drug maker Mallinckrodts (MNK) shares on the heel of Citron Researchs report on the company released last week.

    Earlier today, UBS analyst Marc Goodman and his team weighed into the fray, proclaiming that a misunderstood situation creates opportunity.

    Goodman, who rates Mallinckrodt at a buy with a $92 price target, argues that Mallinckrodt is a different breed from other specialty drug makers, with high-quality earnings, sales growth fueled by volume not price hikes and an emerging pipeline we think is not just underappreciated but really not even part of the conversation with most investors.

    Also, he argues that Mallinckrodt continues to be misunderstood by investors.

    Goodman goes into goes into more detail:

    we were surprised this past week by the debate around Acthar’s Medicare exposure (~30% or ~40%), which in our view has little relevance to the overall MNK story. The key debate since the Questcor deal has been Acthar payer coverage and concerns for more barriers andor coverage blocks by the payers. There was reason for concern just 2 years ago, in our view, as several important payers increased barriers. But mgt’s aggressive focus on enhancing clinical and health-economics data to help support better coverage seems to be working and has resulted in improved coverage, which we believe is still not well appreciated.

    Mallinckrodt shares continue to climb today, rising 4.8% to a recent $57.20.

  • [By Keith Speights]

    That’s the question investors are trying to answer about how President Trump’s policies might impact healthcare stocks. So far, specific policy proposals put forward by the president appear likely to cause significant problems for certain healthcare stocks. Here’s why three of President Trump’s policies could be downright terrible for Molina Healthcare(NYSE:MOH), Mallinckrodt (NYSE:MNK), and Illumina (NASDAQ:ILMN).

  • [By Ben Levisohn]

    Mallinckrodt (MNK) tumbled to the bottom of the S&P 500 today after Citron Research accused the company of fraud.

    Getty Images

    Mallinckrodt tumbled 12% to $59.60 today, while the S&P 500 declined 0.2% to 2,176.94.

    Leerink’s Jason Gerberry and Etzer Darout explain the allegations:

    Mallinckrodtshares are down -7-8% based on a short report citing CMS dashboard data which call into question Acthar Gel sales derived from government sources (CMS; Medicaid & Medicare). The report appears to overstate Acthar CMS sales as a percent of total product sales, as the methodology utilized by CMS drug spending dashboard for Medicare spend is based on gross sales, not net., although it’s unclear to what extent Acthar CMS sales are overstated.

    The report suggestsMallinckrodt mgmt understated combined Medicaid/Medicare sales on an investor call, saying it was about a little bit higher than a quarter of the business vs. gross sales on CMS dashboard implying sales were 61% of total Acthar net revenue (an apples to oranges comparison). We dont know the exact net sales of Acthar to Medicare/Medicaid, but we believe it is safe to assume Medicaid, after CPI price penalties had high discounts/rebates and assuming an 80% gross-to-net ratio on the Medicare book ($504m gross) suggests Acthar net sales would be closer to 38-45% range vs. the 61% figure cited in the short-report. Why this may matter Acthar Gel is an old product lacking good randomized, controlled data consistent with most products approved in the modern era. The report appears to be an attempt to call into question whether the government should be paying Acthars average $80-100k net price/patient/year by calling to this to the attention of government figures who have been targeting excessive drug pricing issues. This type of issue became a major headache for Mylan (MYL) investors recently with EpiPen.Mallinckrodt is presenting at a compe

Top 10 Blue Chip Stocks To Invest In 2019: Apollo Education Group, Inc.(APOL)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q1 2017 earnings report for small cap for-profit education stock Apollo Education Group Inc (NASDAQ: APOL) is scheduled for after the market closes on Monday (January 9th). Last February, Apollo Education Groupannounced a definitive agreement to be acquired by a consortium of investors including The Vistria Group, LLC, funds affiliated with Apollo Global Management, LLC (NYSE: APO), and Najafi Companies for $9.50 per share in cash for both Class A and B shares. However, the for-profit education sector along with certain aspects of the Apollo deal have been targeted by the Obama administration and it remains to be seen how the Trump administration will treat the sector and the deal.

Top 10 Blue Chip Stocks To Invest In 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By CNBC]

    Tony Tribble, Invision/AP
    Forget about Bloomin’ Onions or boneless wings, for many consumers, the choice of where to dine often comes down to a different factor: which restaurant has the best booze.
    “Alcoholic beverages can be a key driver of traffic, differentiation, and loyalty,” said David Decker, president of Consumer Edge Insight. According to the firm, two factors that keep customers coming back are “selection” and “pricing.”
    Consumer Edge Insight recently surveyed restaurant customers to find out which casual-dining spots generated the most loyalty with their alcoholic beverages.
    Taking the top spot for “selection” was Buffalo Wild Wings (BWLD), with 29 percent of those surveyed saying they were “most likely to visit it most often due to its good selection of alcoholic beverages.”
    Applebee’s (DIN) took the second spot, with 24 percent, and Outback Steakhouse (BLMN) and T.G.I. Friday’s tied for third place with 22 percent each.
    Prices also keep customers coming back to Buffalo Wild Wings.

    When asked which casual-dining brand they were “most likely to visit most often due to its good prices of alcoholic beverages,” Buffalo Wild Wings came out on top with 30 percent. Chili’s (EAT) was No. 2 at 23 percent, and Ruby Tuesday (RT) was third with 22 percent.
    Buffalo Wild Wings has always made alcohol a part of its experience, even making it part of its tagline: “Wings.Beer.Sports.”
    The chain is the No. 1 account for more than 50 different beer brands and recently launched Game Changer, a new beer in a partnership with Redhook Brewery. Priced between cheaper domestic lagers and pricier craft beers, Game Changer became the fourth-most-popular draft beer at company-owned locations within two weeks of its release.
    “Among casual-dining restaurants, Buffalo Wild Wings is seeing the greatest positive effect in terms of building customer loyalty with its alcohol offerings,” Decker said. “There are many steps other restaurants can take to improve their alcoho

Top 10 Blue Chip Stocks To Invest In 2019: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Chris Lange]

    Cellect Biotechnology Ltd. (NASDAQ: APOP) reported that it received a formal notice from the U.S. Patent and Trademark Office (USPTO)regarding its method of treatment for immune related disorders. Basically, the USPTO gave a notice of allowance which broadly means the agency intends to issue a patent approval. The treatment method relates to the engineering of regulatory immune cells with enhanced apoptotic activity used for the treatment or prevention for the unmet needs seen in type 1 diabetes, inflammatory bowel disease, graft versus host disease, and transplant rejection.

  • [By Lisa Levin]

    Cellect Biotechnology Ltd. – American Depositary Shares (NASDAQ: APOP) shares were also up, gaining 135 percent to $7.79 after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.

Top 10 Blue Chip Stocks To Invest In 2019: Smith & Wesson Holding Corporation(SWHC)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming volatile higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker TASER International, Inc (NASDAQ: TASR):

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming more volatile and higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker Axon Enterprise (NASDAQ: AAXN), formerlyTASER International, Inc (NASDAQ: TASR):

  • [By Lisa Levin]

    Shares of Smith & Wesson Holding Corp (NASDAQ: SWHC) were down 12 percent to $21.04. Smith & Wesson reported upbeat results for its second quarter, but issued a weak outlook for its third quarter.

  • [By Peter Graham]

    A long term performance chart shows Sturm, Ruger & Company underperforming more volatile but higher flying competitors or peers like small cap gun stock American Outdoor Brands Corp (NASDAQ: AOBC), formerly Smith & Wesson Holding Corp (NASDAQ: SWHC), and electronic control device maker Axon Enterprise (NASDAQ: AAXN), formerlyTASER International, Inc (NASDAQ: TASR):

  • [By Chris Lange]

    Smith & Wesson Holding Corp. (NASDAQ: SWHC) reported fiscal second-quarter financial results after markets closed on Thursday. The company said that it had $0.68 in earnings per share (EPS) and $233.5 million in revenue, versus consensus estimates from Thomson Reuters called for $0.56 in EPS and $227.61 million in revenue. The same period from last year had $0.25 in EPS and $143.24 million in revenue.